Clinical trial Recruiting at 2 sites Observational Ages 40 and up

Registry collecting data on cardiac PET and CardioFlux Magnetocardiography for coronary ischemia detection

Official title: A Registry of Cardiac PET and CardioFlux Magnetocardiography in Patients With Suspected Coronary Ischemia.

Run by Genetesis Inc. · NCT05868902 · Data updated 2026-11-12

This study is collecting information from patients who might have coronary ischemia to see if a new heart imaging method can help find this condition better than the standard tests.

More Coronary Artery Disease trials

Quick facts

Study typeObservational
Ages40 Years and up
SexAll
Enrollment300 (estimated)
SponsorGenetesis Inc.
Industry-sponsored
Locations2 sites (Cleveland, Ohio and 1 other locations)
StatusRecruiting
StartedAugust 28, 2023
Main results expectedJune 1, 2025
Study endsDecember 31, 2025
Registry record updatedFebruary 20, 2025
Trial IDNCT05868902 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals aged 40 and older with a clinical suspicion of myocardial ischemia who have recently completed a cardiac PET.

Probably not a fit

Patients with implanted ferromagnetic devices or those unable to lie supine for the required duration may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational registry aims to gather diagnostic data from patients suspected of having coronary ischemia by utilizing standard cardiac PET imaging. It will also explore the potential role of CardioFlux Magnetocardiography in enhancing the detection of this condition. The study involves multiple centers and focuses on patients who have recently undergone cardiac PET. By analyzing the collected data, researchers hope to improve understanding and diagnostic capabilities for coronary ischemia.

Why it matters

Potential benefit: If successful, this study could lead to improved diagnostic techniques for coronary ischemia, potentially enhancing patient outcomes.

How similar studies have gone: While the use of cardiac PET is well-established, the application of CardioFlux Magnetocardiography in this context is relatively novel and has not been extensively tested in prior studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Willing to provide informed consent
* Male or female, aged 40 and up (inclusive) at the time of enrollment
* Clinical suspicion of myocardial ischemia that clinician desired cardiac PET
* Completed cardiac PET within 2 weeks prior to study enrollment

Exclusion Criteria:

* Patients unable to fit into CardioFlux device.
* Patients unable to lie supine for 5 minutes.
* Patients with implanted ferromagnetic objects above the costal margin of the rib cage (implanted pacemakers, cardioverter/defibrillators, infusion pumps, and/or neuro stimulators). NOTE: Sternotomy wires stents are acceptable
* Ongoing atrial fibrillation or atrial flutter
* Life expectancy \<1 yrs. due to non-cardiovascular comorbidity

Where it's running

  • Cleveland Clinic
    Cleveland, Ohio, United States
    Recruiting
  • Kettering Health
    Kettering, Ohio, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.